Objective: To investigate the effect of medical self-crosslinking sodium hyaluronate gel on endonasal endoscopic
dacryocystorhinostomy (En-DCR). Methods: A total of 219 patients with unilateral chronic dacryocystitis
(CD) were selected and randomly divided into two groups: medical self-crosslinking sodium hyaluronate gel
group (group A) and control group (group B). All patients underwent En-DCR. Group A received medical
self-crosslinking sodium hyaluronate gel filling the ostium at the end of En-DCR, whereas group B received no treatment. Patients were followed-up for 12 months. The mucosal epithelialization of the wound, the granulation
formation, bleeding, and the success rate of ostial patency were compared in the two groups. Results: Our study
included 98 patients in group A and 102 patients in group B. After 2 weeks, the number of absorbable hemostatic
patients who had intact mucosal epithelium lining the ostia was 86 in group A and 77 in group B. At 12 months
follow up, there were 7 patients with scar (7.1%) and 8 patients with granuloma (8.2%) in group A, compared
with 17 patients with scar (16.7%) and 18 patients with granuloma (17.6%) in group B. There were significant
differences in scar formation and granuloma between the two groups (P<0.05). The success rate of anastomotic
patency reached 90.8% (89/98) in group A whereas the success rate was 78.4% (80/102) in group B (P<0.05).
The situation of postoperative bleeding in group B was similar to that in group A (P>0.05). Conclusion: The
medical self-crosslinking sodium hyaluronate gel can improve the success rate of En-DCR treatment of CD
through promoting the healing of anastomotic mucosa and reducing the rate of wound scar and granuloma
formation.